28-04-2021 · Quarterly outlook

From deep value to ‘value with a future’

As the global economy continues to recover, our positive stance on global equity markets remains well underpinned. Both our developed (DM) and emerging markets (EM) teams have remained positive on their respective equity segments.

    Authors

  • Michiel Plakman - Lead Portfolio Manager

    Michiel Plakman

    Lead Portfolio Manager

  • Wim-Hein Pals - Head of Emerging Markets team

    Wim-Hein Pals

    Head of Emerging Markets team

Parts of the world are still wrangling with Covid-19 and lockdowns, and sometime in the second quarter of 2021, the market is likely to start anticipating the dreaded t-word (‘t’ for ‘tapering’). Yet countries are learning to co-exist with a pandemic, the US has sprung on us a USD 1.9 trillion stimulus package, and the Biden administration is working on USD 2.3 trillion in infrastructure investments.

While the fiscal bonanza will impact the US first, the rest of the world will also benefit from its repercussions for global activity. Let’s not forget that the strong recovery expected in global trade is one of the reasons why the International Monetary Fund has lifted its 2021 China GDP growth estimate to an impressive 8.4%.

Clearly, a sizzling economy means higher inflation, but we are still far from levels that would reverse the course of the economic recovery. We are, actually, in the sweet spot for equity markets, as these generally benefit from inflation rising from low levels: historically, the S&P 500 Index has shown outperformance most frequently when CPI was between 1% and 3%.

Both our DM and EM teams have remained positive on their respective equity markets. The only factor that we downgraded, from positive to neutral, is the sentiment factor in EM. We have seen unprecedented investment flows into EM of more than USD 120 billion since October 2020, and we expect inflows to continue but at a slower pace.

Focus on ‘value with a future’

We expect further rotation from the Covid-beneficiary and Covid-defensive stocks to those that will benefit from the economic normalization. This means that value has further outperformance ahead – as long as the economic outlook continues to improve. However, we expect an increased degree of selectivity among investors in their choice of stocks.

Investors will start to look for stocks with the ability to deliver on their perceived value, showing better earnings potential in a normalization of the macroeconomic backdrop. Therefore, after the first wave of value investing boosted all cheap stocks, we expect the second wave to focus on what we call ‘value with a future’, i.e. companies with inexpensive valuations that do not discount their sustained earnings growth ahead.

Our largest overweight across portfolios remains North Asia, although we have taken some profit in China, where we expect market momentum to slow down. Credit growth in the country has peaked, and this is likely to lead earnings to peak. Moreover, around 40% of the weight of the MSCI China Index is in internet-related stocks. This affects the index in the rotation away from expensive and often loss-making digital stocks.

That said, the main change from a country standpoint in our Global Equity portfolios occurred in DM, as we have added to US equities at the expense of Europe. The US is more advanced in fighting the pandemic, and has significantly stepped up fiscal stimulus. We believe that a recovery in the US will be much stronger than in Europe for the foreseeable future, and that US equities will benefit.

Value has further outperformance ahead – as long as the economic outlook continues to improve.

Stay informed on our latest insights with monthly mail updates

Receive our Robeco newsletter and be the first to read the latest insights and build the greenest portfolio.

Stay updated

Download the publication

Important information

The contents of this document have not been reviewed by the Securities and Futures Commission ("SFC") in Hong Kong. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. This document has been distributed by Robeco Hong Kong Limited (‘Robeco’). Robeco is regulated by the SFC in Hong Kong. This document has been prepared on a confidential basis solely for the recipient and is for information purposes only. Any reproduction or distribution of this documentation, in whole or in part, or the disclosure of its contents, without the prior written consent of Robeco, is prohibited. By accepting this documentation, the recipient agrees to the foregoing This document is intended to provide the reader with information on Robeco’s specific capabilities, but does not constitute a recommendation to buy or sell certain securities or investment products. Investment decisions should only be based on the relevant prospectus and on thorough financial, fiscal and legal advice. Please refer to the relevant offering documents for details including the risk factors before making any investment decisions. The contents of this document are based upon sources of information believed to be reliable. This document is not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. Investment Involves risks. Historical returns are provided for illustrative purposes only and do not necessarily reflect Robeco’s expectations for the future. The value of your investments may fluctuate. Past performance is no indication of current or future performance.